| Literature DB >> 33875427 |
Elizabeth Diller1, Tamara Krekel1, Andrej Spec2, Jeff Klaus1.
Abstract
This retrospective single-center study of a cohort of adult patients who received voriconazole with a steady-state trough concentration measured during therapy evaluated the rate of therapeutic trough attainment using adjusted body weight (AdjBW)-based and total body weight (TBW)-based dosing in overweight and obese patients. Of the 130 patients included, 45 patients received TBW-based dosing and 85 patients received AdjBW-based dosing. Therapeutic trough attainment was significantly improved with AdjBW-based dosing compared to TBW-based dosing (64.7% versus 46.7%; P = 0.047).Entities:
Keywords: anti-infection agents; antifungal therapy; azole antifungals; azoles; drug monitoring; fungal infections; obesity; therapeutic drug monitoring; voriconazole
Mesh:
Substances:
Year: 2021 PMID: 33875427 PMCID: PMC8218689 DOI: 10.1128/AAC.02460-20
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191